Upcoming Digital Health Monthly:
Scientific Webinar Series
Accelerating DHT Research and Drug Development with Open-Source Big Data from Population Studies
Tuesday, December 3 @ 12 PM ET
Digital Health Monthly: Scientific Webinar Series
Sensor-based DHTs are shedding an illuminating light on how people function in their real-world environments. Drug developers, researchers, patients, and regulators are realizing the multifaceted value sensor-based DHTs can bring to clinical research.
As their adoption continues to grow, the ActiGraph team is excited to continue ‘Digital Health Monthly’, a monthly series of science-focused webinars to share the latest high-impact developments in clinical research from innovators in the digital health field. Each month, we feature brief data-driven presentations from clinical researchers, data scientists, and biostatisticians on a focused topic with dedicated time for audience Q&A. We believe that together, we can move the digital health technology field forward faster, and we are excited for this opportunity to facilitate important discussions on the latest research with members of the digital health community.
Accelerating DHT Research and Drug Development with Open-source Big Data from Population Studies
In our last Digital Health Monthly session of 2024, we’ll focus on the scope and utility of the National Health and Nutrition Examination Survey (NHANES), a program of studies designed to assess the health status of individuals in the United States. Large-scale population studies like NHANES provide clinical researchers with a rich and diverse data set that otherwise they would not have the means to collect, expanding the analyses researchers can perform to address key health-related questions.
Data collected during this survey has included physical activity and sleep behavior data captured by wearable DHTs since the early 2000s, which has been used in thousands of epidemiological and health sciences research studies.
Dr. Dana Wolff-Hughes, Program Director at the NIH, will provide an overview of NHANES and share details on the data collection plans for the upcoming survey, including the addition of vital sign data using wearable DHTs.
Dr. Andy Liu, Biostatistician at ActiGraph, will discuss a recent project utilizing actigraphy data from NHANES to develop best practices to derive reliable clinical outcome scores from continuous DHT data.
Both academic researchers and clinical development professionals will learn more about this unique and rich data set, and how they can leverage this data to advance their research.
Speakers
